These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 6835724)
1. Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda. Baron R; Gertner JM; Lang R; Vignery A Pediatr Res; 1983 Mar; 17(3):204-7. PubMed ID: 6835724 [TBL] [Abstract][Full Text] [Related]
2. Bone cell defects in osteogenesis imperfecta. Vignery A Connect Tissue Res; 1995; 31(4):275-8. PubMed ID: 15612367 [TBL] [Abstract][Full Text] [Related]
3. Osteogenesis imperfecta tarda. The morphology of rib biopsies. Albright JP; Albright JA; Crelin ES Clin Orthop Relat Res; 1975 May; (108):204-13. PubMed ID: 1139829 [TBL] [Abstract][Full Text] [Related]
4. Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations. Roschger P; Fratzl-Zelman N; Misof BM; Glorieux FH; Klaushofer K; Rauch F Calcif Tissue Int; 2008 Apr; 82(4):263-70. PubMed ID: 18311573 [TBL] [Abstract][Full Text] [Related]
5. Cell proliferation of human fibroblasts and osteoblasts in osteogenesis imperfecta: influence of age. Fedarko NS; D'Avis P; Frazier CR; Burrill MJ; Fergusson V; Tayback M; Sponseller PD; Shapiro JR J Bone Miner Res; 1995 Nov; 10(11):1705-12. PubMed ID: 8592947 [TBL] [Abstract][Full Text] [Related]
6. The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. Rauch F; Travers R; Plotkin H; Glorieux FH J Clin Invest; 2002 Nov; 110(9):1293-9. PubMed ID: 12417568 [TBL] [Abstract][Full Text] [Related]
7. [Pathologic anatomy of osteogenesis imperfecta. Light and electron microscopic studies of supportive tissue and skin]. Stöss H Veroff Pathol; 1990; 134():1-88. PubMed ID: 2385955 [TBL] [Abstract][Full Text] [Related]
8. Enzyme histochemical localisation of alkaline phosphatase activity in osteogenesis imperfecta bone and growth plate: a preliminary study. Sarathchandra P; Cassella JP; Ali SY Micron; 2005; 36(7-8):715-20. PubMed ID: 16182549 [TBL] [Abstract][Full Text] [Related]
9. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen. Marini JC; Hopkins E; Glorieux FH; Chrousos GP; Reynolds JC; Gundberg CM; Reing CM J Bone Miner Res; 2003 Feb; 18(2):237-43. PubMed ID: 12568401 [TBL] [Abstract][Full Text] [Related]
10. Iliac bone histomorphometry in adults and children with osteogenesis imperfecta. Ste-Marie LG; Charhon SA; Edouard C; Chapuy MC; Meunier PJ J Clin Pathol; 1984 Oct; 37(10):1081-9. PubMed ID: 6490947 [TBL] [Abstract][Full Text] [Related]
11. Relationship between vitamin D status and bone mineralization, mass, and metabolism in children with osteogenesis imperfecta: histomorphometric study. Edouard T; Glorieux FH; Rauch F J Bone Miner Res; 2011 Sep; 26(9):2245-51. PubMed ID: 21544864 [TBL] [Abstract][Full Text] [Related]
12. The effect of intravenous pamidronate on bone mineral density, bone histomorphometry, and parameters of bone turnover in adults with type IA osteogenesis imperfecta. Shapiro JR; McCarthy EF; Rossiter K; Ernest K; Gelman R; Fedarko N; Santiago HT; Bober M Calcif Tissue Int; 2003 Feb; 72(2):103-12. PubMed ID: 12457260 [TBL] [Abstract][Full Text] [Related]
13. Comparison of nanoindentation measurements between osteogenesis imperfecta Type III and Type IV and between different anatomic locations (femur/tibia versus iliac crest). Fan Z; Smith PA; Harris GF; Rauch F; Bajorunaite R Connect Tissue Res; 2007; 48(2):70-5. PubMed ID: 17453908 [TBL] [Abstract][Full Text] [Related]
14. Deficient bone formation in idiopathic juvenile osteoporosis: a histomorphometric study of cancellous iliac bone. Rauch F; Travers R; Norman ME; Taylor A; Parfitt AM; Glorieux FH J Bone Miner Res; 2000 May; 15(5):957-63. PubMed ID: 10804027 [TBL] [Abstract][Full Text] [Related]
15. Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta. Weber M; Roschger P; Fratzl-Zelman N; Schöberl T; Rauch F; Glorieux FH; Fratzl P; Klaushofer K Bone; 2006 Sep; 39(3):616-22. PubMed ID: 16644299 [TBL] [Abstract][Full Text] [Related]
16. Increased bone resorption with decreased activity and increased recruitment of osteoblasts in osteogenesis imperfecta type I. Iwamoto J; Takeda T; Ichimura S J Bone Miner Metab; 2002; 20(3):174-9. PubMed ID: 11984701 [TBL] [Abstract][Full Text] [Related]
17. Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta. Rauch F; Lalic L; Roughley P; Glorieux FH J Bone Miner Res; 2010 Jun; 25(6):1367-74. PubMed ID: 19929435 [TBL] [Abstract][Full Text] [Related]
18. Long-term extracellular matrix metabolism by cultured human osteogenesis imperfecta osteoblasts. Fedarko NS; Sponseller PD; Shapiro JR J Bone Miner Res; 1996 Jun; 11(6):800-5. PubMed ID: 8725177 [TBL] [Abstract][Full Text] [Related]
19. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. Glorieux FH; Ward LM; Rauch F; Lalic L; Roughley PJ; Travers R J Bone Miner Res; 2002 Jan; 17(1):30-8. PubMed ID: 11771667 [TBL] [Abstract][Full Text] [Related]
20. Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study. Rauch F; Munns CF; Land C; Cheung M; Glorieux FH J Bone Miner Res; 2009 Jul; 24(7):1282-9. PubMed ID: 19257821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]